within Pharmacolibrary.Drugs.ATC.N;

model N02AJ15
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 4.9999999999999996e-06,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0027,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.003,
    Tlag           = 600,            
    Vdp             = 0.0021000000000000003,
    k12             = 1.7,
    k21             = 1.7
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N02AJ15</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Combination of tramadol, an opioid analgesic with both opioid receptor agonist and monoaminergic reuptake inhibition properties, and other non-opioid analgesics. This combination is used for the management of moderate to severe pain where the use of a combination therapy is considered appropriate. This drug combination is approved and marketed in some countries under various brand names.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adults, typical oral fixed-dose product combining tramadol and a non-opioid analgesic. No specific population PK studies reported for the combination.</p><h4>References</h4><ol><li><p>Richard, MJ, et al., &amp; McAlindon, TE (2023). Pharmaceutical treatment of osteoarthritis. <i>Osteoarthritis and cartilage</i> 31(4) 458–466. DOI:<a href=&quot;https://doi.org/10.1016/j.joca.2022.11.005&quot;>10.1016/j.joca.2022.11.005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36414224/&quot;>https://pubmed.ncbi.nlm.nih.gov/36414224</a></p></li><li><p>Saiz-Rodríguez, M, et al., &amp; Abad-Santos, F (2020). Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics. <i>Pharmacogenomics</i> 21(10) 663–675. DOI:<a href=&quot;https://doi.org/10.2217/pgs-2020-0026&quot;>10.2217/pgs-2020-0026</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32538291/&quot;>https://pubmed.ncbi.nlm.nih.gov/32538291</a></p></li><li><p>Cho, JH, &amp; Choi, HG (2021). Acetaminophen and tramadol hydrochloride-loaded soft gelatin capsule: preparation, dissolution and pharmacokinetics in beagle dogs. <i>Pharmaceutical development and technology</i> 26(5) 576–581. DOI:<a href=&quot;https://doi.org/10.1080/10837450.2021.1903036&quot;>10.1080/10837450.2021.1903036</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33719822/&quot;>https://pubmed.ncbi.nlm.nih.gov/33719822</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N02AJ15;
